This is just about to take-off again like last time only this time it will be absolutely much higher than before. Buyout rumors on Stockhouse are claiming that 20 Dollars/share is to cheap and with the potential of wonder drug WF-10 ending Phase two and positioning for a Phase 3 will be an instant hit when the announcement comes out on their test results Mid-February that have appeared to go well. A Nasdaq listing is also rumored to be a definite consideration according to the company. Nuvo Research is going to have an amazing 2015 !!